Chaperonopathies and Chaperonotherapy. Hsp60 as Therapeutic Target in Cancer: Potential Benefits and Risks

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|3|452-457

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.3, 2013-01, pp. : 452-457

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Therapeutic Target Hsp90 and Cancer Hallmarks

By  

Current Pharmaceutical Design, Vol. 19, Iss. 3, 2013-01 ,pp. : 347-365

Bentham Science Publishers

Access to resources Recommend Favorite

HSP60 as a Drug Target

By  

Current Pharmaceutical Design, Vol. 19, Iss. 3, 2013-01 ,pp. : 441-451

Bentham Science Publishers

Access to resources Recommend Favorite

Telomerase: a potential therapeutic target for cancer

By Fletcher Terace M  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 457-469

Informa Healthcare

Access to resources Recommend Favorite

The potential of carboxypeptidase M as a therapeutic target in cancer

By Denis Catherine J   Lambeir Anne-Marie  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 3, 2013-03 ,pp. : 265-279

Informa Healthcare

Access to resources Recommend Favorite

FOXP1: a potential therapeutic target in cancer

By Koon Henry B   Ippolito Gregory C   Banham Alison H   Tucker Philip W  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 7, 2007-07 ,pp. : 955-965

Informa Healthcare

Access to resources Recommend Favorite